Menkes disease (MD) is a neurodegenerative disorder characterized by copper deˆciency. It is caused by defective intestinal absorption of copper resulting from a deˆciency of a copper-transporting ATPase, ATP7A. We investigated the eŠects of combination therapy with copper and disulˆram, a known lipophilic chelator. We synthesized a copperdisulˆram complex (Cu-DSF) and determined its crystal structure by X-ray crystallographic analysis. Unfortunately, Cu-DSF was not orally bioavailable due to its lipophilicity. We therefore planned to use cyclodextrin as a solubilizing agent to increase the water solubility of Cu-DSF. After comparisons of the eŠects of cyclodextrins (a, b, g), it was found that addition of b-cyclodextrin (b-CyD) increased the solubility of Cu-DSF. Moreover, the modiˆed b-CyD, hydroxypropyl-b-cyclodextrin, was yet more eŠective as a solubilizing agent. For the development of a convenient method to determine the concentration of Cu-DSF included by b-cyclodextrins, a standard curve based on UV-visible(VIS) absorption was derived.
Cu-DSF が包接され，0.86 mmol/L の濃度になるこ 
